Aurinia Pharmaceuticals Inc. financial data

Symbol
AUPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
#140, 14315 118 Avenue, Edmonton, Alberta, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 555 % -39%
Quick Ratio 50.5 % -15.8%
Debt-to-equity 43.5 % +101%
Return On Equity -13.5 % +25.3%
Return On Assets -9.4 % +36.7%
Operating Margin -29.3 % +43.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 143M shares -0.3%
Common Stock, Shares, Outstanding 143M shares -0.27%
Entity Public Float 1.38B USD -2.82%
Weighted Average Number of Shares Outstanding, Basic 143M shares +0.39%
Weighted Average Number of Shares Outstanding, Diluted 144M shares +0.93%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 207M USD +29.3%
Cost of Revenue 28.8M USD +398%
Research and Development Expense 33.5M USD -28.3%
General and Administrative Expense 190M USD -3.25%
Costs and Expenses 268M USD +10%
Operating Income (Loss) -60.7M USD +27.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -48.1M USD +32.4%
Income Tax Expense (Benefit) 2.25M USD +40.5%
Net Income (Loss) Attributable to Parent -50.3M USD +30.8%
Earnings Per Share, Basic -0.34 USD/shares +32%
Earnings Per Share, Diluted -0.34 USD/shares +32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.3M USD -59.1%
Inventory, Net 38.9M USD +17.2%
Other Assets, Current 6.98M USD +477%
Assets, Current 410M USD -1.5%
Property, Plant and Equipment, Net 3.04M USD -16.6%
Operating Lease, Right-of-Use Asset 4.29M USD -9.04%
Other Assets, Noncurrent 867K USD -42.9%
Assets 524M USD -4.62%
Employee-related Liabilities, Current 11.4M USD -19%
Contract with Customer, Liability, Current 4.37M USD +35.3%
Liabilities, Current 76.9M USD +24.7%
Operating Lease, Liability, Noncurrent 6.15M USD -9.8%
Other Liabilities, Noncurrent 10.9M USD +25.6%
Liabilities 159M USD +1.47%
Accumulated Other Comprehensive Income (Loss), Net of Tax -859K USD +15.8%
Retained Earnings (Accumulated Deficit) -952M USD -5.58%
Stockholders' Equity Attributable to Parent 365M USD -7.06%
Liabilities and Equity 524M USD -4.62%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +41.3%
Net Cash Provided by (Used in) Financing Activities -15.1M USD -1018%
Net Cash Provided by (Used in) Investing Activities 49.2M USD +98%
Common Stock, Shares, Issued 143M shares -0.27%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 15.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33.4M USD -59.1%
Deferred Tax Assets, Valuation Allowance 162M USD -1.59%
Deferred Tax Assets, Gross 183M USD +9.75%
Operating Lease, Liability 7.15M USD -7.9%
Depreciation 4.85M USD +576%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.2M USD +30.2%
Lessee, Operating Lease, Liability, to be Paid 8.6M USD -10.5%
Property, Plant and Equipment, Gross 5.26M USD +0.27%
Operating Lease, Liability, Current 1.01M USD +5.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD +2.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD +2.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.44M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.2M USD +2.39%
Deferred Tax Assets, Operating Loss Carryforwards 138M USD -2.21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.23M USD +2.34%
Operating Lease, Payments 276K USD +4.94%
Amortization of Intangible Assets 1.1M USD -47.6%
Deferred Tax Assets, Net of Valuation Allowance 20.6M USD +1043%
Share-based Payment Arrangement, Expense 37.9M USD +2.55%
Interest Expense 5.19M USD +1743%